Protocol No: TLC599A2003 Name of Finished Product: TLC599~Title of Study:~A Phase IIa, Randomized, Double blinded, Placebo controlled, Dose finding Study for Single dose Administration of TLC599 in Patients with Osteoarthritis (OA) of Knee.~Study duration:~The trial will last around 27 weeks including a 21-day screening period and a 24-week follow-up period.
This trial is a Phase IIa, Randomized, Double blinded, Placebo controlled, Dose finding Study to investigate the safety and efficacy of TLC599 in subjects with osteoarthritis of the knee.